Cell replacement as a route to treat cellular disease and injury is cu
rrently limited by the availability of suitable donor cell populations
, but recent results with mouse embryonic stem cells suggest that isol
ated human pluripotent cells could provide a source of cells for trans
plantation and gene therapy.